manya sadat hashemian

The aim of the current research was to provide an intelligent model of the green supply chain of pharmaceutical products with the overlap of common customers. This research applies simulation to the proposed model of a pharmaceutical supply chain with smart and green conditions. The society under investigation is the environment of pharmaceutical companies, with its specific assumptions and goals. This model is simulated in the GMAS software environment. The problem was examined from two perspectives: simultaneous production (coordination of drugs) and cooperative planning (coordination of suppliers). Additionally, in order to address the issue of vehicle routing under real conditions of limited capacity for delivery vehicles, the expiration date of the drug and time windows in orders were taken into consideration. The objective was to allocate orders to vehicles in a way that minimizes the total delivery time and reduces the amount of carbon dioxide produced. Based on the obtained results, this multi-objective model aims to improve the performance of the pharmaceutical distribution network by addressing three main complexities: economic, environmental, and social. This approach provides a comprehensive and balanced solution for designing the drug distribution network. Its goal is to preserve the environment, improve social conditions, and maximize economic profit.